InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+9.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Pizzie Nick, Chief Financial Officer. Officer active across 1 company, notably Axsome Therapeutics, Inc.. Aggregated, 5 disclosures have been published. Split: 2 buys · 1 sell. Total volume traded: €33k. Activity tracked since 18 November 2021. The latest transaction was filed on 13 February 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
33,000 sharesCommon StockSEC:0001193125-26-264035:0
33,000 sharesCommon StockSEC:0001193125-26-264035:1
12,000 shares@ US$3.5055.0% of flowCommon StockSEC:0000950170-25-021716:0
527 shares@ US$35.5022.5% of flowCommon StockSEC:0001209191-21-066005
Ideal exit: 15 Aug 2022 (T+270)
527 shares@ US$35.500.0002% mcap50.0% of flowCommon StockSEC:0001209191-21-066005:0
Ideal exit: 15 Aug 2022 (T+270)
5 of 5 declarations
About Pizzie Nick
Nick Pizzie is the Chief Financial Officer of Axsome Therapeutics, Inc. He is responsible for the financial management of the company, overseeing financial operations and strategic planning. Nick plays a key role in optimizing financial performance and achieving Axsome's growth objectives.
